BioNexus Gene Lab
BGLC
HK$35.01
Share price
-1.98%
Change (1 day)
814.48%
Change (1 year)
Categories
Earnings for BioNexus Gene Lab (BGLC)
Earnings in 2025 (TTM): -HK$16.59 Million
According to BioNexus Gene Lab's latest financial reports the company's current earnings are HK$9.26 Million. In 2024 the company made an earning of -HK$12.52 Million, an increase over its 2023 earnings that were of -HK$20.48 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for BioNexus Gene Lab from 2019 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -HK$16.59 Million | 32.48% |
| 2024 | -HK$12.52 Million | -38.86% |
| 2023 | -HK$20.48 Million | 759.05% |
| 2022 | -HK$2.39 Million | -129.12% |
| 2021 | HK$8.18 M | -61.45% |
| 2020 | HK$21.23 M | -1081.23% |
| 2019 | -HK$2.17 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -HK$1.16 Billion | 6,769.23% | 🇺🇸 USA |